Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avexis Inc (AVXS)

Avexis Inc (AVXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,020,501
  • Shares Outstanding, K 36,820
  • Annual Sales, $ 0 K
  • Annual Income, $ -218,050 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.09
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12.34
  • Most Recent Earnings $-2.55 on 02/27/18
  • Next Earnings Date 05/10/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate -2.10
  • Number of Estimates 4
  • High Estimate -1.30
  • Low Estimate -2.59
  • Prior Year -2.07
  • Growth Rate Est. (year over year) -1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
205.00 +6.31%
on 04/20/18
217.94 unch
on 05/15/18
+6.80 (+3.22%)
since 04/13/18
3-Month
112.93 +92.99%
on 02/20/18
217.94 unch
on 05/15/18
+101.83 (+87.70%)
since 02/15/18
52-Week
65.54 +232.53%
on 05/31/17
217.94 unch
on 05/15/18
+145.40 (+200.44%)
since 05/15/17

Business Summary

AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Company's product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 218.06
1st Resistance Point 217.94
Last Price 217.94
1st Support Level 217.71
2nd Support Level 217.60
3rd Support Level N/A

See More

52-Week High 217.94
Last Price 217.94
Fibonacci 61.8% 159.72
Fibonacci 50% 141.74
Fibonacci 38.2% 123.76
52-Week Low 65.54

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar